TARGET(N = 126) | |
---|---|
Gender | |
Female | 70(55.56%) |
Male | 56(44.44%) |
Age | |
< 3 years | 33(26.19%) |
> 3 years | 93(73.80%) |
Stage | |
I-II | 68(53.97%) |
III-IV | 58(46.03%) |
Evenet | |
Relapse/progression | 101(80.06%) |
None | 25(19.84) |
TICAM1 | |
High-expression` | 51(40.48%) |
Low-expression | 75(59.52%) |